Skip to main content
TEVA $42.62 +0.12%
TEVA logo
TEVA · Teva Pharmaceutical Industries Ltd
Track TEVA — free
$42.62 +0.05 (+0.12%) At close · Nov 17 Play latest call Q3 2026 earnings call transcript
Market Cap
$49.73B
Shares
1.17B
Volume · Nov 17 7.02M Avg daily vol (3M) 6.16M
All webcasts

Earnings call · FY2022 Q4

Teva Pharmaceutical Industries Ltd (TEVA) Q4 2022 Earnings Call

Concluded Feb 8, 2023
Feb 8, 2023
Period
FY2022 Q4
Runtime
—
Sources
2 artifacts
Revenue · derived Q4 $3.88B -5.3% YoY
Diluted EPS -$1.17
Gross margin · derived Q4 45.6% -4.4 pp YoY
Net income -$1.30B
Open full screen 8-K 10-K

Executive readout · one minute

Webcast research workspace

Read the call alongside every captured source. 8-K earnings release, 10-K stay in one workspace.

Forward guidance

4 guided metrics

Management's latest ranges and targets are included below.

Research coverage

2 live sources

Open each available source without leaving this research workspace.

Research materials

Open the source you need; every reader stays inside this workspace.

Forward guidance

From the 8-K filed Feb 8, 2023.

Metric Guided Actual
Revenues
2023
$14.8B – $15.4B $15.85B above
Adjusted EBITDA
2023
$4.5B – $4.9B —
Non-GAAP diluted EPS
2023
$2.25 – $2.55 —
Free cash flow
2023
$1.7B – $2.1B —
Full-screen source Call document